Bristol-Myers Squibb had a positive return on equity of 11.94% and a negative net margin of 15.30%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis.

(RTTNews) - Biopharma major Bristol-Myers Squibb Company (BMY) said Friday that it received a positive opinion from the Committee for Medicinal Products for Human Use or CHMP of the European ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Goldman Sachs analyst warns 340B reforms could shift profits to biopharma, benefiting companies like Merck and Gilead. Proposed Medicaid cuts may create risks for biopharma, impacting drugs like ...

As we enter 2020, I asked leaders from Pfizer and Bristol-Myers Squibb to share their unique perspectives as early adopters and advocates of RWE. Tanvi Shah, director of alliance management at ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

TV Insider was on the scene and, following the Q&A panel, chatted up executive producer Steve Holland about Barber’s return, who else from Young Sheldon might appear again and/or next on Georgie ...